UAE Launches Gene Therapy Projects for Neurological Care

The UAE has announced two pioneering gene therapy projects targeting rare neurological and genetic disorders in children. Led by the Emirates Health Services (EHS) and in partnership with the Children’s Hospital of Philadelphia, these initiatives aim to transition healthcare from merely managing symptoms to directly addressing genetic causes. The projects focus on conditions like monogenic autism and aim to create advanced therapies using novel gene delivery systems designed for specific brain cells, potentially improving treatment effectiveness and safety while lowering costs.

The implications of these projects are significant for national health strategies. By integrating artificial intelligence and data-driven approaches, the UAE seeks to leverage its Emirati Genome Programme for better early diagnosis and interventions. This strategic shift towards innovation-driven healthcare aims to improve quality of life and build local capabilities in biotechnology. As the UAE invests in addressing genetic disorders, it enhances national autonomy in healthcare while setting a precedent for future medical advancements in the region.